ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data.

doi:10.2130/JIM.0b013e31823581fa

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 1 Dec 2011

Wilcox Charles S, Noble Ernest P, Oskooilar Nader

Abstract excerpt

BACKGROUND: Polymorphism of the DRD2 gene (rs1800497), previously termed Taq1A, includes the A1 and A2 alleles. The A1⁺ genotype (A1/A1, A1/A2) has been associated with smoking dependence. The present study determined which polymorphism of the DRD2 gene had a salutary outcome in administration of rimonabant, a drug used in smoking cessation and obesity studies. METHODS: Seventy-six (76) smokers enrolled into a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbon Monoxide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Loci

Share to Pilot Projects

Share to Piperidines

Share to Protein Serine-Threonine Kinases

Share to Pyrazoles

Share to Receptors, Dopamine D2

Share to Smoking Cessation

Source

Open in PubMed

Identifiers

PMID: 21997315
DOI: 10.2130/JIM.0b013e31823581fa

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data.PMID 21997315Read ↗

The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations.Semantic proximity Read ↗

Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy.Semantic proximity Read ↗

DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Semantic proximity Read ↗

DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers.Semantic proximity Read ↗

Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.Semantic proximity Read ↗

A DRD2 and ANKK1 haplotype is associated with nicotine dependence.Semantic proximity Read ↗

Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.Semantic proximity Read ↗

Pharmacogenetics of nicotine addiction: role of dopamine.Semantic proximity Read ↗

Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials.Semantic proximity Read ↗

Polymorphisms in the DBH and DRD2 gene regions and smoking behavior.Semantic proximity Read ↗

Prospective association of dopamine-related polymorphisms with smoking cessation in general care.Semantic proximity Read ↗

Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.